Authors' Response to Yoshihiro Noguchi's Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)"

Drug Saf. 2022 Dec;45(12):1553-1555. doi: 10.1007/s40264-022-01239-3. Epub 2022 Oct 12.
No abstract available

Publication types

  • Letter
  • Research Support, U.S. Gov't, P.H.S.
  • Comment

MeSH terms

  • Adverse Drug Reaction Reporting Systems*
  • Clonidine
  • Cytochrome P-450 CYP1A2
  • Cytochrome P-450 CYP1A2 Inhibitors*
  • Drug Interactions
  • Humans

Substances

  • Cytochrome P-450 CYP1A2 Inhibitors
  • tizanidine
  • Clonidine
  • CYP1A2 protein, human
  • Cytochrome P-450 CYP1A2